Smartleaf Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Hold
1,120
0.01% 762
2026
Q1
$221K Sell
1,120
-22
-2% -$4.27K 0.01% 753
2025
Q4
$200K Buy
1,142
+236
+26% +$43K 0.01% 798
2025
Q3
$171K Buy
906
+234
+35% +$41.5K 0.01% 791
2025
Q2
$120K Sell
672
-180
-21% -$31.3K 0.01% 797
2025
Q1
$143K Buy
852
+110
+15% +$18.1K 0.01% 689
2024
Q4
$112K Buy
742
+110
+17% +$17.1K 0.01% 794
2024
Q3
$97.9K Buy
632
+268
+74% +$40K 0.01% 714
2024
Q2
$50K Buy
364
+53
+17% +$7.26K 0.01% 741
2024
Q1
$40.8K Buy
311
+227
+270% +$29.5K 0.01% 723
2023
Q4
$11.6K Buy
+84
New +$11K ﹤0.01% 744

Other funds holding DGX

Smartleaf Asset Management's DGX Position: Q2 2026 in Review

Smartleaf Asset Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,120 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #762.

Smartleaf Asset Management first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Smartleaf Asset Management held 1,120 shares of Quest Diagnostics worth $238K as of Q2 2026.
  • Smartleaf Asset Management left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #762 holding.
  • Smartleaf Asset Management first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.